Day One Biopharmaceutical... (DAWN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
13.33
0.56 (4.39%)
At close: Jan 28, 2025, 3:01 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -6.17 | -10.66 | -14.82 | -35.93 | -98.93 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.36 | -5.22 | -8.19 | -26.85 | -136.36 |
P/FCF Ratio | -7.76 | -12.82 | -18.46 | -107.16 | -322.33 |
P/OCF Ratio | -7.93 | -12.82 | -21.51 | -107.89 | -322.33 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | -0.00 | -0.00 | -0.01 | n/a |
Quick Ratio | 12.72 | 20.94 | 33.43 | 22.58 | 13.53 |
Current Ratio | 12.72 | 20.94 | 33.43 | 22.58 | 13.53 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -30.95 | -18.19K | -459.4 | -7.18 |
Return on Equity (ROE) | -0.55 | 0.49 | 0.55 | 0.75 | 1.38 |
Return on Assets (ROA) | -0.5 | -0.38 | -0.24 | -0.89 | -0.54 |
Return on Capital (ROIC) | -0.59 | -0.44 | -0.26 | -0.32 | -0.59 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |